These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20461888)

  • 1. [Melanoma and non-melanoma skin cancers].
    Saida T
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):624. PubMed ID: 20461888
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic manual of malignant melanoma].
    Moroi Y
    Fukuoka Igaku Zasshi; 2009 Feb; 100(2):51-8. PubMed ID: 19455975
    [No Abstract]   [Full Text] [Related]  

  • 3. [To outwit melanoma with its own tricks].
    Bischoff A
    MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of melanoma with an emphasis on immunotherapeutic strategies.
    Jack A; Boyes C; Aydin N; Alam K; Wallack M
    Surg Oncol; 2006 Jul; 15(1):13-24. PubMed ID: 16815006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to re-evaluate sentinel node biopsy in melanoma post-multicenter selective lymphadenectomy trial.
    Thomas JM
    J Clin Oncol; 2005 Dec; 23(36):9443-4. PubMed ID: 16361650
    [No Abstract]   [Full Text] [Related]  

  • 6. Current treatment of cutaneous melanoma and the sentinel lymph node.
    Bruns SD; McGee JM; Phillips JW
    J Okla State Med Assoc; 2002 May; 95(5):332-5. PubMed ID: 12043108
    [No Abstract]   [Full Text] [Related]  

  • 7. [Melanoma].
    Saida T
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1386-91. PubMed ID: 17033225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ki-67 expression in melanoma. A potential method of risk assessment for the patient with a positive sentinel node.
    Pearl RA; Pacifico MD; Richman PI; Stott DJ; Wilson GD; Grobbelaar AO
    J Exp Clin Cancer Res; 2007 Mar; 26(1):109-15. PubMed ID: 17550139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging therapies for melanoma.
    Katipamula R; Markovic SN
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):553-60. PubMed ID: 18402522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New aspects of immunotherapy of malignant melanoma].
    Enk A
    Praxis (Bern 1994); 2001 Mar; 90(10):403-6. PubMed ID: 11305186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current management of patients with melanoma who are pregnant, want to get pregnant, or do not want to get pregnant.
    Schwartz JL; Mozurkewich EL; Johnson TM
    Cancer; 2003 May; 97(9):2130-3. PubMed ID: 12712462
    [No Abstract]   [Full Text] [Related]  

  • 12. Melanoma--part 2: management.
    Thirlwell C; Nathan P
    BMJ; 2008 Dec; 337():a2488. PubMed ID: 19047194
    [No Abstract]   [Full Text] [Related]  

  • 13. [Future of malignant stage I melanoma. Immunology and immunotherapy].
    Nicolas JF; Berthier O; Trillet-Lenoir V; Claudy A; Revillard JP
    Ann Dermatol Venereol; 1995; 122(5):324-35. PubMed ID: 8572476
    [No Abstract]   [Full Text] [Related]  

  • 14. Is sentinel node status predictive of overall survival in patients with melanoma?
    Carlson GW
    Nat Clin Pract Oncol; 2005 Oct; 2(10):494-5. PubMed ID: 16205765
    [No Abstract]   [Full Text] [Related]  

  • 15. Sentinel lymph node biopsy and completion lymph node dissection for malignant melanoma are not standard of care.
    Coldiron BM; Dinehart S; Rogers HW
    Clin Dermatol; 2009; 27(4):350-4. PubMed ID: 19539161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic mapping and sentinel lymphadenectomy for melanoma: past, present, and future.
    Morton DL
    Ann Surg Oncol; 2001 Oct; 8(9 Suppl):22S-28S. PubMed ID: 11599892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma.
    Pawlik TM; Ross MI; Prieto VG; Ballo MT; Johnson MM; Mansfield PF; Lee JE; Cormier JN; Gershenwald JE
    Cancer; 2006 Feb; 106(4):900-6. PubMed ID: 16411225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic analysis of sentinel lymph nodes in melanoma patients: current and future trends.
    Roberts AA; Cochran AJ
    J Surg Oncol; 2004 Mar; 85(3):152-61. PubMed ID: 14991887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guidelines for clinical practice: Standards, Options and Recommendations 2005 for the management of adult patients exhibiting an M0 cutaneous melanoma, full report. National Federation of Cancer Campaign Centers. French Dermatology Society. Update of the 1995 Consensus Conference and the 1998 Standards, Options, and Recommendations].
    Négrier S; Saiag P; Guillot B; Verola O; Avril MF; Bailly C; Cupissol D; Dalac S; Danino A; Dreno B; Grob JJ; Leccia MT; Renaud-Vilmer C; Bosquet L; ;
    Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 2):10S3-10S85. PubMed ID: 16521904
    [No Abstract]   [Full Text] [Related]  

  • 20. [Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but not therapeutic implications].
    Kruit WH;
    Ned Tijdschr Geneeskd; 2008 Mar; 152(10):574-6. PubMed ID: 18402325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.